FDA widening probe into heart drugs linked to cancer risk
The FDA issued a statement saying it is “still not 100 percent sure" of the root cause.”
After learning an ingredient used to make a widely prescribed heart drug contained a substance linked to cancer, the Food and Drug Administration is now testing all drugs in that class for traces of the toxic material.
The probe into angiotensin II receptor blockers is part of a widening investigation into a mystery over an impurity known as NDMA, which was found
